Opaleye Management »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Opaleye Management

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Opaleye Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0M 6.0M 0.66
2024-06-30 $3.7M 6.0M 0.62

More positions owned by Opaleye Management

Harrow Health (HROW)
Tg Therapeutics (TGTX)
Ocular Therapeutix (OCUL)
Arvinas Ord (ARVN)
Codexis (CDXS)
Rhythm Pharmaceuticals (RYTM)
Keros Therapeutics (KROS)
Immunome (IMNM)
Liquidia Corporation Com New (LQDA)
Eton Pharmaceuticals (ETON)
Edgewise Therapeutics (EWTX)
Cargo Therapeutics (CRGX)
Applied Therapeutics (APLT)
Vaxcyte (PCVX)
Nurix Therapeutics (NRIX)

View all positions for Opaleye Management

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Affinity Asset Advisors
Opaleye Management
Capstone Investment Advisors
BLB^B Advisors
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1